WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ムコ多糖症：臨床的特徴および診断 mucopolysaccharidoses clinical features and diagnosis
2. 血小板生物学 platelet biology
3. ムコ多糖症：合併症およびマネージメント mucopolysaccharidoses complications and management
4. 先天性および後天性血小板機能障害 congenital and acquired disorders of platelet function
5. 肝ホスホリラーゼ欠損症（糖原病VI型、エール病） liver phosphorylase deficiency glycogen storage disease vi hers disease

Unraveling the mechanism responsible for the contrasting tolerance of Synechocystis and Synechococcus to Cr(VI): Enzymatic and non-enzymatic antioxidants.

Gupta A1, Ballal A2.
Aquatic toxicology (Amsterdam, Netherlands).Aquat Toxicol.2015 Jul;164:118-25. doi: 10.1016/j.aquatox.2015.04.015. Epub 2015 Apr 17.
Two unicellular cyanobacteria, Synechocystis and Synechococcus, showed contrasting tolerance to Cr(VI); with Synechococcus being 12-fold more tolerant than Synechocystis to potassium dichromate. The mechanism responsible for this differential sensitivity to Cr(VI) was explored in this study. Total c
PMID 25956322

High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index.

Kuusisto ME1, Haapasaari KM2, Turpeenniemi-Hujanen T1, Jantunen E3, Soini Y4, Peroja P1, Bloigu R5, Karihtala P1, Kuittinen O1.
Journal of clinical pathology.J Clin Pathol.2015 Jul;68(7):552-6. doi: 10.1136/jclinpath-2014-202771. Epub 2015 May 2.
AIMS: Diffuse large B-cell lymphoma (DLBCL) is an aggressive and potentially fatal disease. Prediction of risk of relapse is based on clinical markers. There is a need for more accurate biomarkers to select patients for more aggressive first-line treatments. Peroxiredoxins (Prxs) are a family of pot
PMID 25935550

Solution structure of the reduced form of human peroxiredoxin-6 elucidated using zero-length chemical cross-linking and homology modelling.

Rivera-Santiago RF1, Harper SL1, Zhou S2, Sriswasdi S1, Feinstein SI2, Fisher AB2, Speicher DW1.
The Biochemical journal.Biochem J.2015 May 15;468(1):87-98. doi: 10.1042/BJ20141463.
Peroxiredoxin-6 (PRDX6) is an unusual member of the peroxiredoxin family of antioxidant enzymes that has only one evolutionarily conserved cysteine. It reduces oxidized lipids and reactive oxygen species (ROS) by oxidation of the active-site cysteine (Cys(47)) to a sulfenic acid, but the mechanism f
PMID 25748205

Proteomics Analysis of Apoptosis-regulating Proteins in Tissues with Different Radiosensitivity

AN Jeung Hee,SEONG Jin Sil
Journal of radiation research 47(2), 147-155, 2006-06-30
… Analysis of liver tissue showed that the expression level of ROS related proteins such as cytochrome c, glutathione S transferase, NADH dehydrogenase and peroxiredoxin VI increased after radiation. …
NAID 110004740242

Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma

:/<文字列>　：　文字列 を検索する（順方向） 
:?<文字列>　：　文字列を検索する（逆方向） 
:n　　　　　：　順方向へ検索する  
:N　　　　　：　逆方向へ検索する

:q　　　　　：　(何も変更していない場合)保存せずに終了
:q!　　　　　：　(何か変更した場合)保存せずに終了